217 related articles for article (PubMed ID: 26333108)
1. Evaluation of pro-inflammatory markers plasma C-reactive protein and urinary prostaglandin-E2 metabolite in colorectal adenoma risk.
Davenport JR; Cai Q; Ness RM; Milne G; Zhao Z; Smalley WE; Zheng W; Shrubsole MJ
Mol Carcinog; 2016 Aug; 55(8):1251-61. PubMed ID: 26333108
[TBL] [Abstract][Full Text] [Related]
2. Urinary prostaglandin E2 metabolite and risk for colorectal adenoma.
Shrubsole MJ; Cai Q; Wen W; Milne G; Smalley WE; Chen Z; Ness RM; Zheng W
Cancer Prev Res (Phila); 2012 Feb; 5(2):336-42. PubMed ID: 22166248
[TBL] [Abstract][Full Text] [Related]
3. Plasma Inflammatory Markers and Risk of Advanced Colorectal Adenoma in Women.
Song M; Mehta RS; Wu K; Fuchs CS; Ogino S; Giovannucci EL; Chan AT
Cancer Prev Res (Phila); 2016 Jan; 9(1):27-34. PubMed ID: 26511487
[TBL] [Abstract][Full Text] [Related]
4. Dietary Inflammatory Potential and the Risk of Serrated and Adenomatous Colorectal Polyps.
Sung LB; Coleman HG; Shivappa N; Hébert JR; Murff HJ; Milne GL; Ness RM; Smalley WE; Zheng W; Shrubsole MJ
Nutr Cancer; 2023; 75(10):1900-1910. PubMed ID: 37791878
[TBL] [Abstract][Full Text] [Related]
5. Urinary PGE-M levels are associated with risk of colorectal adenomas and chemopreventive response to anti-inflammatory drugs.
Bezawada N; Song M; Wu K; Mehta RS; Milne GL; Ogino S; Fuchs CS; Giovannucci EL; Chan AT
Cancer Prev Res (Phila); 2014 Jul; 7(7):758-65. PubMed ID: 24824037
[TBL] [Abstract][Full Text] [Related]
6. Prospective study of urinary prostaglandin E2 metabolite and colorectal cancer risk.
Cai Q; Gao YT; Chow WH; Shu XO; Yang G; Ji BT; Wen W; Rothman N; Li HL; Morrow JD; Zheng W
J Clin Oncol; 2006 Nov; 24(31):5010-6. PubMed ID: 17075120
[TBL] [Abstract][Full Text] [Related]
7. A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trial.
Hull MA; Sandell AC; Montgomery AA; Logan RF; Clifford GM; Rees CJ; Loadman PM; Whitham D
Trials; 2013 Jul; 14():237. PubMed ID: 23895505
[TBL] [Abstract][Full Text] [Related]
8. Urine PGE-M: A metabolite of prostaglandin E2 as a potential biomarker of advanced colorectal neoplasia.
Johnson JC; Schmidt CR; Shrubsole MJ; Billheimer DD; Joshi PR; Morrow JD; Heslin MJ; Washington MK; Ness RM; Zheng W; Schwartz DA; Coffey RJ; Beauchamp RD; Merchant NB
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1358-65. PubMed ID: 16996805
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein and risk of colorectal adenomas or serrated polyps: a prospective study.
Crockett SD; Mott LA; Barry EL; Figueiredo JC; Burke CA; Baxter GJ; Sandler RS; Baron JA
Cancer Prev Res (Phila); 2014 Nov; 7(11):1122-7. PubMed ID: 25145487
[TBL] [Abstract][Full Text] [Related]
10. A prospective evaluation of C-reactive protein levels and colorectal adenoma development.
Gunter MJ; Cross AJ; Huang WY; Stanczyk FZ; Purdue M; Xue X; Schoen R; Limburg PJ; Schatzkin A; Sinha R; Hayes RB
Cancer Epidemiol Biomarkers Prev; 2011 Mar; 20(3):537-44. PubMed ID: 21212059
[TBL] [Abstract][Full Text] [Related]
11. Correlation between Metabolite of Prostaglandin E2 and the incidence of colorectal adenomas.
Jiang J; Li A; Lai X; Zhang H; Wang C; Wang H; Li L; Liu Y; Xie L; Yang C; Zhang C; Lu S; Li Y
Front Oncol; 2023; 13():1068469. PubMed ID: 36923425
[TBL] [Abstract][Full Text] [Related]
12. [C-reactive protein level and colorectal adenoma].
Park SK; Park DI; Park JH; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI; Kim JE; Son HJ
Korean J Gastroenterol; 2008 Apr; 51(4):225-31. PubMed ID: 18516001
[TBL] [Abstract][Full Text] [Related]
13. Markers of systemic inflammation and colorectal adenoma risk: Meta-analysis of observational studies.
Godos J; Biondi A; Galvano F; Basile F; Sciacca S; Giovannucci EL; Grosso G
World J Gastroenterol; 2017 Mar; 23(10):1909-1919. PubMed ID: 28348498
[TBL] [Abstract][Full Text] [Related]
14. Association of plasma C-reactive protein level with the prevalence of colorectal adenoma: the Colorectal Adenoma Study in Tokyo.
Kigawa N; Budhathoki S; Yamaji T; Iwasaki M; Inoue M; Tsugane S
Sci Rep; 2017 Jun; 7(1):4456. PubMed ID: 28667300
[TBL] [Abstract][Full Text] [Related]
15. Associations of cigarette smoking and alcohol consumption with advanced or multiple colorectal adenoma risks: a colonoscopy-based case-control study in Korea.
Shin A; Hong CW; Sohn DK; Chang Kim B; Han KS; Chang HJ; Kim J; Oh JH
Am J Epidemiol; 2011 Sep; 174(5):552-62. PubMed ID: 21791710
[TBL] [Abstract][Full Text] [Related]
16. Levels of prostaglandin E metabolite, the major urinary metabolite of prostaglandin E2, are increased in smokers.
Gross ND; Boyle JO; Morrow JD; Williams MK; Moskowitz CS; Subbaramaiah K; Dannenberg AJ; Duffield-Lillico AJ
Clin Cancer Res; 2005 Aug; 11(16):6087-93. PubMed ID: 16115954
[TBL] [Abstract][Full Text] [Related]
17. Do we need colonoscopy in patients with gastric adenomas? The risk of colorectal adenoma in patients with gastric adenomas.
Yang MH; Son HJ; Lee JH; Kim MH; Kim JY; Kim YH; Chang DK; Rhee PL; Kim JJ; Rhee JC
Gastrointest Endosc; 2010 Apr; 71(4):774-81. PubMed ID: 20363417
[TBL] [Abstract][Full Text] [Related]
18. Five-year colon surveillance after screening colonoscopy.
Lieberman DA; Weiss DG; Harford WV; Ahnen DJ; Provenzale D; Sontag SJ; Schnell TG; Chejfec G; Campbell DR; Kidao J; Bond JH; Nelson DB; Triadafilopoulos G; Ramirez FC; Collins JF; Johnston TK; McQuaid KR; Garewal H; Sampliner RE; Esquivel R; Robertson D
Gastroenterology; 2007 Oct; 133(4):1077-85. PubMed ID: 17698067
[TBL] [Abstract][Full Text] [Related]
19. Elevation of C-reactive protein level is associated with synchronous and advanced colorectal neoplasm in men.
Chiu HM; Lin JT; Chen TH; Lee YC; Chiu YH; Liang JT; Shun CT; Wu MS
Am J Gastroenterol; 2008 Sep; 103(9):2317-25. PubMed ID: 18844617
[TBL] [Abstract][Full Text] [Related]
20. Risk of colorectal cancer and adenomas in the families of patients with adenomas: a population-based study in Utah.
Tuohy TM; Rowe KG; Mineau GP; Pimentel R; Burt RW; Samadder NJ
Cancer; 2014 Jan; 120(1):35-42. PubMed ID: 24150925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
